These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1498 related items for PubMed ID: 20123726

  • 1. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
    Schmierer K, Parkes HG, So PW, An SF, Brandner S, Ordidge RJ, Yousry TA, Miller DH.
    Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
    [Abstract] [Full Text] [Related]

  • 2. Spinal cord grey matter lesions in multiple sclerosis detected by post-mortem high field MR imaging.
    Gilmore CP, Geurts JJ, Evangelou N, Bot JC, van Schijndel RA, Pouwels PJ, Barkhof F, Bö L.
    Mult Scler; 2009 Feb; 15(2):180-8. PubMed ID: 18845658
    [Abstract] [Full Text] [Related]

  • 3. Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective.
    Vrenken H, Geurts JJ.
    Expert Rev Neurother; 2007 Mar; 7(3):271-9. PubMed ID: 17341175
    [Abstract] [Full Text] [Related]

  • 4. Cortical pathology in multiple sclerosis.
    Stadelmann C, Albert M, Wegner C, Brück W.
    Curr Opin Neurol; 2008 Jun; 21(3):229-34. PubMed ID: 18451703
    [Abstract] [Full Text] [Related]

  • 5. Focal thinning of the cerebral cortex in multiple sclerosis.
    Sailer M, Fischl B, Salat D, Tempelmann C, Schönfeld MA, Busa E, Bodammer N, Heinze HJ, Dale A.
    Brain; 2003 Aug; 126(Pt 8):1734-44. PubMed ID: 12805100
    [Abstract] [Full Text] [Related]

  • 6. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.
    Narayanan S, Francis SJ, Sled JG, Santos AC, Antel S, Levesque I, Brass S, Lapierre Y, Sappey-Marinier D, Pike GB, Arnold DL.
    Neuroimage; 2006 Jan 15; 29(2):637-42. PubMed ID: 16126413
    [Abstract] [Full Text] [Related]

  • 7. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
    Sinnecker T, Mittelstaedt P, Dörr J, Pfueller CF, Harms L, Niendorf T, Paul F, Wuerfel J.
    Arch Neurol; 2012 Jun 15; 69(6):739-45. PubMed ID: 22351849
    [Abstract] [Full Text] [Related]

  • 8. Diffusion-weighted MR of the brain: methodology and clinical application.
    Mascalchi M, Filippi M, Floris R, Fonda C, Gasparotti R, Villari N.
    Radiol Med; 2005 Mar 15; 109(3):155-97. PubMed ID: 15775887
    [Abstract] [Full Text] [Related]

  • 9. White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.
    Parry A, Clare S, Jenkinson M, Smith S, Palace J, Matthews PM.
    J Neurol; 2002 Sep 15; 249(9):1279-86. PubMed ID: 12242554
    [Abstract] [Full Text] [Related]

  • 10. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
    Barkhof F, van Walderveen M.
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct 29; 354(1390):1675-86. PubMed ID: 10603619
    [Abstract] [Full Text] [Related]

  • 11. Characterization of white matter damage in animal models of multiple sclerosis by magnetization transfer ratio and quantitative mapping of the apparent bound proton fraction f.
    Rausch M, Tofts P, Lervik P, Walmsley A, Mir A, Schubart A, Seabrook T.
    Mult Scler; 2009 Jan 29; 15(1):16-27. PubMed ID: 18971220
    [Abstract] [Full Text] [Related]

  • 12. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
    Zivadinov R, Sepcić J.
    Lijec Vjesn; 2006 Jan 29; 128(9-10):295-308. PubMed ID: 17128669
    [Abstract] [Full Text] [Related]

  • 13. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis.
    Bö L, Geurts JJ, van der Valk P, Polman C, Barkhof F.
    Arch Neurol; 2007 Jan 29; 64(1):76-80. PubMed ID: 17210812
    [Abstract] [Full Text] [Related]

  • 14. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
    Vercellino M, Masera S, Lorenzatti M, Condello C, Merola A, Mattioda A, Tribolo A, Capello E, Mancardi GL, Mutani R, Giordana MT, Cavalla P.
    J Neuropathol Exp Neurol; 2009 May 29; 68(5):489-502. PubMed ID: 19525897
    [Abstract] [Full Text] [Related]

  • 15. Imaging correlates of axonal swelling in chronic multiple sclerosis brains.
    Fisher E, Chang A, Fox RJ, Tkach JA, Svarovsky T, Nakamura K, Rudick RA, Trapp BD.
    Ann Neurol; 2007 Sep 29; 62(3):219-28. PubMed ID: 17427920
    [Abstract] [Full Text] [Related]

  • 16. Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging.
    Chard D, Miller D.
    J Neurol Sci; 2009 Jul 15; 282(1-2):5-11. PubMed ID: 19201002
    [Abstract] [Full Text] [Related]

  • 17. MR in the diagnosis and monitoring of multiple sclerosis: an overview.
    Rovira A, León A.
    Eur J Radiol; 2008 Sep 15; 67(3):409-14. PubMed ID: 18434066
    [Abstract] [Full Text] [Related]

  • 18. Quantitative MRI-pathology correlations of brain white matter lesions developing in a non-human primate model of multiple sclerosis.
    Blezer EL, Bauer J, Brok HP, Nicolay K, 't Hart BA.
    NMR Biomed; 2007 Apr 15; 20(2):90-103. PubMed ID: 16948176
    [Abstract] [Full Text] [Related]

  • 19. Pathological correlates of magnetization transfer imaging abnormalities in animal models and humans with multiple sclerosis.
    Brochet B, Dousset V.
    Neurology; 1999 Apr 15; 53(5 Suppl 3):S12-7. PubMed ID: 10496205
    [Abstract] [Full Text] [Related]

  • 20. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    Sastre-Garriga J, Arévalo MJ, Renom M, Alonso J, González I, Galán I, Montalban X, Rovira A.
    J Neurol Sci; 2009 Jul 15; 282(1-2):120-4. PubMed ID: 19157420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 75.